A few months ago, I got an email from a pharmacist.
She wanted to know whether I’d be able to get a prescription for an antibiotic that had been approved by the Food and Drug Administration for $2,000 a dose.
“It’s not like we don’t have a prescription,” she said.
But, she added, “you don’t get a full price.”
That was my first clue that the pharmaceutical industry is trying to keep out the most cost-effective drugs.
So I clicked on the link and was greeted with a $150 price tag.
“There are several drugs that you can get from the FDA that are very expensive,” I heard her say.
But not the $2.50 one.
“Not $2,” I replied.
“Just $150,” she replied.
And so I went on, searching for other options, hoping to find the one that I could afford.
And I couldn’t.
In the United States, drug prices can vary dramatically depending on which company is selling it.
The Food and Pharmaceutical Administration (FDA) sets the price for the majority of prescription drugs, and the prices vary depending on the type of drug, the company and the country.
But in the United Kingdom, the pharmaceutical companies have the power to set their own prices, so the most expensive drug in the world can be much more expensive than the most affordable.
But the drug companies have largely refused to lower their prices.
“I have had to resort to calling drugstores to get them to lower the price of my antibiotics,” said Sarah Baskin, a 29-year-old medical assistant in Cambridge, Massachusetts, who was recently able to afford an antibiotic for $300.
“They said it was a drug that’s no good for me and that it would take me a year to get used to.”
In the past decade, drug companies, including Johnson & Johnson and Novartis, have been pushing to lower drug prices.
In 2014, the FDA approved a drug called erythromycin, which is used to treat the common cold, pneumonia and the flu.
It is also widely used to fight cancer and treat autoimmune diseases, such as psoriasis.
The drug is sold under the brand name Seroquel, and it costs $10 for 100 milligrams, or a single tablet.
The price of a single dose of the drug is $150.
But generic versions of the same drug are available for as little as $40.
And in 2015, Pfizer, the world’s largest drugmaker, launched a generic version of erythrocyte-boosting medication Zocor, which has a price tag of $5 for 100mg, or one tablet.
Generic versions of this drug, which can be used without a prescription, are available at about $5 a pill.
The company says the generic versions are safer and less expensive than its original version.
But a study by the American Medical Association found that more than 20 million prescriptions were filled with generic versions, including a generic versions sold in pharmacies across the United State, the United and Canadian provinces.
“This drug is no different than any other generic drug that we’re trying to bring in,” said Peter Loughlin, president of the American Academy of Allergy, Asthma and Immunology.
“We’re trying desperately to get these drugs into the hands of people who need them.”
The generic versions often are made by generic makers like Novartas, which was bought by Pfizer for $13.6 billion in 2014.
But Pfizer has refused to sell the generic version, and has not made any changes to the formulation of the drugs it makes.
But there is a growing movement to make generic versions more affordable, as well.
Earlier this year, for instance, the Food &